---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-003118"
form_type: "8-K"
ticker: "BPTH"
cik: "0001133818"
company_name: "BIO-PATH HOLDINGS, INC."
filed_at: "2024-03-13T23:59:59+00:00"
generated_at: "2026-06-04T22:02:43.571189+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Bio-Path receives Nasdaq delisting notice for failing $2.5M equity minimum

## Summary
- Deficiency letter received March 12, 2024 citing non-compliance with Nasdaq Listing Rule 5550(b)(1).
- Company has until April 26, 2024 to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant up to 180 days extension to cure deficiency.
- Common stock continues trading on Nasdaq Capital Market under symbol BPTH pending review.
- Company evaluating options but no assurance of regaining compliance or avoiding delisting.

## SEC filing metadata
- accession: 0001558370-24-003118
- form_type: 8-K
- ticker: BPTH
- cik: 0001133818
- company_name: BIO-PATH HOLDINGS, INC.
- filed_at: 2024-03-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133818/000155837024003118/0001558370-24-003118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133818/000155837024003118/bpth-20240312x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-003118
- JSON: https://secwatch.observer/filing/0001558370-24-003118.json
- Plain text: https://secwatch.observer/filing/0001558370-24-003118.txt

## Key facts
- Listing & Compliance Notices
  BIO-PATH HOLDINGS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: March 12, 2024, Bio-Path Holdings, Inc. (the “Company”) received a deficiency letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement of at least $2,500,000 for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”). The Letter has no effect on the listing of the Company’s common stock at this time, and the Company’s common stock will continue to trade on The Nasdaq C
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133818/000155837024003118/0001558370-24-003118-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.